Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS TrialKyaw Aung, Jennifer J. Knox, Anna Dodd et al.|Clinical Cancer Research|2017Cited by 635
Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancerPier‐Luc Clermont, Cheryl D. Helgason, Francesco Crea et al.|Clinical Epigenetics|2016Cited by 78